Cancer Treatment Facilities Market Report 2026

The cancer treatment facilities market size has grown strongly in recent years. It will grow from $48.27 billion in 2025 to $52.19 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising global cancer incidence rates, expansion of hospital oncology departments, availability of chemotherapy and radiation technologies, increasing awareness of early cancer detection, growth in trained oncology professionals.

The cancer treatment facilities market size is expected to see strong growth in the next few years. It will grow to $70.52 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing investments in cancer research infrastructure, rising adoption of immunotherapy and targeted therapies, expansion of personalized medicine approaches, growing use of digital health in oncology care, increasing demand for integrated cancer treatment services. Major trends in the forecast period include increasing adoption of precision oncology treatments, rising integration of advanced diagnostic technologies, growing use of multidisciplinary care models, expansion of specialized cancer centers, enhanced focus on patient-centric care.

The increasing prevalence of cancer is expected to drive the growth of the cancer treatment facilities market in the coming years. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. The rising prevalence of cancer is primarily due to an aging population, as older age groups face a significantly higher risk of developing the disease. Cancer treatment facilities address this growing cancer burden by providing early detection, advanced therapeutic options, and continuous care, which are critical for improving patient survival and quality of life. For instance, in September 2025, according to the American Association for Cancer Research (AACR), a US-based professional organization dedicated to cancer research and prevention, there were an estimated 20 million new cancer cases and over 10.3 million cancer-related deaths globally in 2025, with approximately 53.5 million people surviving at least five years after a cancer diagnosis. Therefore, the increasing prevalence of cancer is propelling the growth of the cancer treatment facilities market.

Key companies operating in the cancer treatment facilities market are focusing on advanced treatment technologies, such as electron beam therapy, to improve the precision and efficacy of cancer care. Electron beam therapy involves the use of high-energy electrons to treat tumors located near the surface of the body. For example, in October 2024, Aster DM Healthcare Limited, a UAE-based healthcare company, launched intraoperative electron radiation therapy (IOeRT) in its cancer treatment facilities. IOeRT delivers a high-dose, single-fraction electron beam directly to the tumor bed during surgery, using direct visualization to target residual cancer cells precisely while shielding healthy tissues. The high-energy electrons (typically 4-12 MeV) provide a sharp dose fall-off, minimizing radiation exposure to deeper tissue layers.

In December 2024, Reliance Industries Limited, an India-based conglomerate, acquired Karkinos Healthcare for $44 million. Through this acquisition, Reliance aims to strengthen its presence in the digital healthcare ecosystem and expand access to advanced oncology solutions across India. Karkinos Healthcare is an India-based cancer care technology platform specializing in cancer treatment facilities.

Major companies operating in the cancer treatment facilities market are Kaiser Permanente, HCA Healthcare Inc., CommonSpirit Health, Ascension Health, Trinity Health Corporation, Tenet Healthcare Corporation, Adventist Health System Sunbelt Healthcare Corporation, Universal Health Services Inc., Community Health Systems Inc., Ramsay Health Care Limited, Sutter Health, Stanford Health Care, Netcare Limited, Allegheny Health Network, IHH Healthcare Berhad, Fortis Healthcare, LifePoint Health Inc., Aster DM Healthcare Limited, Prime Healthcare Services Inc., Providence Health & Services.

Asia-Pacific was the largest region in the cancer treatment facilities market in 2025, and it is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer treatment facilities market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cancer treatment facilities market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cancer treatment facilities market by increasing costs of imported medical imaging systems, radiotherapy equipment, surgical instruments, and advanced diagnostic devices. Hospitals and cancer centers in North America and Europe are most affected due to dependence on imported high-end medical technologies, while Asia-Pacific faces higher capital costs for facility expansion. These tariffs are increasing treatment infrastructure costs and delaying equipment upgrades. However, they are also encouraging domestic manufacturing of medical devices, regional supplier development, and greater investment in localized healthcare infrastructure.

The cancer treatment facilities market research report is one of a series of new reports that provides cancer treatment facilities market statistics, including cancer treatment facilities industry global market size, regional shares, competitors with a cancer treatment facilities market share, detailed cancer treatment facilities market segments, market trends and opportunities, and any further data you may need to thrive in the cancer treatment facilities industry. This cancer treatment facilities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cancer treatment facilities refer to specialized medical centers or institutions that provide comprehensive care for patients diagnosed with cancer. These facilities utilize advanced medical technologies, multidisciplinary healthcare teams, and evidence-based treatment protocols to diagnose, treat, and manage cancer effectively, with the goal of improving patient outcomes and quality of life.

The primary types of cancer treatment facilities are blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, colorectal cancer, lung cancer, and other cancer types. Blood cancer refers to malignancies that originate in the blood or bone marrow, affecting the production and function of blood cells. These facilities provide various treatment types, including cancer surgery, chemotherapy, radiation therapy, immunotherapy, bone marrow transplantation, and other therapeutic interventions. They serve a wide range of end-users, including hospitals, oncology centers, specialty clinics, and cancer research institutions.

The cancer treatment facilities market includes revenues earned by entities by providing services such as imaging, chemotherapy administration, tumor removal surgeries, pain management, and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.